A&G Pharmaceutical is a company deveoping personalized cancer therapeutics.
A&G Pharmaceutical is a biotechnology company developing personalized therapies for detecting and treating cancer and other human diseases that is headquartered in Columbia, Maryland and was founded in 2000 by Ginette Serrero, Gordon Sato, and Jun Hayashi.
On April 27, 2010 A&G Pharmaceutical completed a venture capital round with $100,000 thousand in funding from undisclosed investors.
On September 8, 2005 A&G Pharmaceutical completed their series A funding round with $2 million in funding from New England Partners (lead investor), Maryland Venture Fund, and Crocker Capital.
A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement
NCI Awards A&G Pharmaceutical $2 million for Clinical Trial in Lung Cancer
November 1, 2012
A&G Pharmaceutical, Inc. "Developing Therapeutic & Diagnostic for Breast and Lung Cancers"
August 28, 2012
A&G Pharmaceutical: Fighting Cancer.avi
March 7, 2012
A company deveoping personalized cancer therapeutics
No more activity to show.